Industry: Service & Software
Published Date: 2025-05-08
Pages: 156 Pages
Report ld: 4727332
Request Sample
Customized Report
Neurology CRO Services Market Size(US$)

CAGR 2025-2031
5.3%
Market Size,2031
USD 1,040
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
Neurology Contract Research Organization (CRO) services are specialized offerings provided by external entities to pharmaceutical companies, biotech firms, academic institutions, and other stakeholders engaged in neurological research and drug development. These CROs possess in-depth expertise in the complex field of neurology, encompassing a wide range of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. Their services span various stages of the research and development process. They are involved in the design and planning of clinical trials, carefully formulating study protocols, defining appropriate endpoints, and identifying suitable patient populations based on the specific neurological condition under investigation. Neurology CROs handle patient recruitment and enrollment, leveraging their networks with specialized neurology clinics, hospitals, and patient advocacy groups to ensure a diverse and representative sample of participants. They also manage data collection, analysis, and interpretation, dealing with the intricate data related to neurological symptoms, cognitive function, and biomarker measurements. Additionally, they offer regulatory support, helping clients navigate the complex and evolving regulatory landscape for neurological therapies, ensuring compliance with relevant guidelines. These services are essential for accelerating the development of effective treatments for neurological disorders, as they allow organizations to access the specialized skills, resources, and experience of the CROs, ultimately aiming to improve the lives of patients suffering from neurological conditions.
The US & Canada market for Neurology CRO Services is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Neurology CRO Services is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Neurology CRO Services is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key manufacturers of Neurology CRO Services include Parexel, Atlantic Research Group, Linical, Biospective, InnoSer, MDB Neuro, Charles River Laboratories, MCRA, Syneos Health, Biotrial, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Neurology CRO Services production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Neurology CRO Services by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Neurology CRO Services, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Neurology CRO Services, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Neurology CRO Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurology CRO Services sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Neurology CRO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Neurology CRO Services sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Parexel, Atlantic Research Group, Linical, Biospective, InnoSer, MDB Neuro, Charles River Laboratories, MCRA, Syneos Health, Biotrial, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Neurology CRO Services production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Neurology CRO Services in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Neurology CRO Services manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurology CRO Services sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurology CRO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Clinical Trial Management Services
1.2.3 Pre-clinical Research Services
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neurology CRO Services Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Academic Research Organizations
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurology CRO Services Market Perspective (2020-2031)
2.2 Global Neurology CRO Services Growth Trends by Region
2.2.1 Global Neurology CRO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neurology CRO Services Market Size by Region (2020-2031)
2.3 Neurology CRO Services Market Dynamics
2.3.1 Neurology CRO Services Industry Trends
2.3.2 Neurology CRO Services Market Drivers
2.3.3 Neurology CRO Services Market Challenges
2.3.4 Neurology CRO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neurology CRO Services by Players
3.1.1 Global Neurology CRO Services Revenue by Players (2020-2025)
3.1.2 Global Neurology CRO Services Revenue Market Share by Players (2020-2025)
3.2 Global Neurology CRO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neurology CRO Services, Ranking by Revenue, 2023 VS 2024 VS 2025
3.4 Global Market Concentration Ratio
3.4.1 Global Neurology CRO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurology CRO Services Revenue in 2024
3.5 Global Key Players of Neurology CRO Services Head office and Area Served
3.6 Global Key Players of Neurology CRO Services, Product and Application
3.7 Global Key Players of Neurology CRO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Neurology CRO Services Historic Market Size by Type (2020-2025)
4.2 Global Neurology CRO Services Forecasted Market Size by Type (2026-2031)
5 Breakdown Data by Application
5.1 Global Neurology CRO Services Historic Market Size by Application (2020-2025)
5.2 Global Neurology CRO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neurology CRO Services Market Size (2020-2031)
6.2 North America Market Size by Type
6.2.1 North America Neurology CRO Services Market Size by Type (2020-2031)
6.2.2 North America Neurology CRO Services Market Share by Type (2020-2031)
6.3 North America Market Size by Application
6.3.1 North America Neurology CRO Services Market Size by Application (2020-2031)
6.3.2 North America Neurology CRO Services Market Share by Application (2020-2031)
6.4 North America Market Size by Country
6.4.1 North America Neurology CRO Services Market Size by Country: 2020 VS 2024 VS 2031
6.4.2 North America Neurology CRO Services Market Size by Country (2020-2031)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Neurology CRO Services Market Size (2020-2031)
7.2 Europe Market Size by Type
7.2.1 Europe Neurology CRO Services Market Size by Type (2020-2031)
7.2.2 Europe Neurology CRO Services Market Share by Type (2020-2031)
7.3 Europe Market Size by Application
7.3.1 Europe Neurology CRO Services Market Size by Application (2020-2031)
7.3.2 Europe Neurology CRO Services Market Share by Application (2020-2031)
7.4 Europe Market Size by Country
7.4.1 Europe Neurology CRO Services Market Size by Country: 2020 VS 2024 VS 2031
7.4.2 Europe Neurology CRO Services Market Size by Country (2020-2025)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neurology CRO Services Market Size (2020-2031)
8.2 China Market Size by Type
8.2.1 China Neurology CRO Services Market Size by Type (2020-2031)
8.2.2 China Neurology CRO Services Market Share by Type (2020-2031)
8.3 China Market Size by Application
8.3.1 China Neurology CRO Services Market Size by Application (2020-2031)
8.3.2 China Neurology CRO Services Market Share by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Neurology CRO Services Market Size (2020-2031)
9.2 Asia Market Size by Type
9.2.1 Asia Neurology CRO Services Market Size by Type (2020-2031)
9.2.2 Asia Neurology CRO Services Market Share by Type (2020-2031)
9.3 Asia Market Size by Application
9.3.1 Asia Neurology CRO Services Market Size by Application (2020-2031)
9.3.2 Asia Neurology CRO Services Market Share by Application (2020-2031)
9.4 Asia Market Size by Region
9.4.1 Asia Neurology CRO Services Market Size by Region: 2020 VS 2024 VS 2031
9.4.2 Asia Neurology CRO Services Market Size by Region (2020-2031)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neurology CRO Services Market Size (2020-2031)
10.2 Middle East, Africa, and Latin America Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neurology CRO Services Market Size by Type (2020-2031)
10.2.2 Middle East, Africa, and Latin America Neurology CRO Services Market Share by Type (2020-2031)
10.3 Middle East, Africa, and Latin America Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neurology CRO Services Market Size by Application (2020-2031)
10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
10.4 Middle East, Africa, and Latin America Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neurology CRO Services Market Size by Country: 2020 VS 2024 VS 2031
10.4.2 Middle East, Africa, and Latin America Neurology CRO Services Market Size by Country (2020-2031)
10.4.3 Brazil
10.4.4 Mexico
10.4.5 Turkey
10.4.6 Saudi Arabia
10.4.7 Israel
10.4.8 GCC Countries
11 Key Players Profiles
11.1 Parexel
11.1.1 Parexel Company Details
11.1.2 Parexel Business Overview
11.1.3 Parexel Neurology CRO Services Introduction
11.1.4 Parexel Revenue in Neurology CRO Services Business (2020-2025)
11.1.5 Parexel Recent Development
11.2 Atlantic Research Group
11.2.1 Atlantic Research Group Company Details
11.2.2 Atlantic Research Group Business Overview
11.2.3 Atlantic Research Group Neurology CRO Services Introduction
11.2.4 Atlantic Research Group Revenue in Neurology CRO Services Business (2020-2025)
11.2.5 Atlantic Research Group Recent Development
11.3 Linical
11.3.1 Linical Company Details
11.3.2 Linical Business Overview
11.3.3 Linical Neurology CRO Services Introduction
11.3.4 Linical Revenue in Neurology CRO Services Business (2020-2025)
11.3.5 Linical Recent Development
11.4 Biospective
11.4.1 Biospective Company Details
11.4.2 Biospective Business Overview
11.4.3 Biospective Neurology CRO Services Introduction
11.4.4 Biospective Revenue in Neurology CRO Services Business (2020-2025)
11.4.5 Biospective Recent Development
11.5 InnoSer
11.5.1 InnoSer Company Details
11.5.2 InnoSer Business Overview
11.5.3 InnoSer Neurology CRO Services Introduction
11.5.4 InnoSer Revenue in Neurology CRO Services Business (2020-2025)
11.5.5 InnoSer Recent Development
11.6 MDB Neuro
11.6.1 MDB Neuro Company Details
11.6.2 MDB Neuro Business Overview
11.6.3 MDB Neuro Neurology CRO Services Introduction
11.6.4 MDB Neuro Revenue in Neurology CRO Services Business (2020-2025)
11.6.5 MDB Neuro Recent Development
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Details
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Neurology CRO Services Introduction
11.7.4 Charles River Laboratories Revenue in Neurology CRO Services Business (2020-2025)
11.7.5 Charles River Laboratories Recent Development
11.8 MCRA
11.8.1 MCRA Company Details
11.8.2 MCRA Business Overview
11.8.3 MCRA Neurology CRO Services Introduction
11.8.4 MCRA Revenue in Neurology CRO Services Business (2020-2025)
11.8.5 MCRA Recent Development
11.9 Syneos Health
11.9.1 Syneos Health Company Details
11.9.2 Syneos Health Business Overview
11.9.3 Syneos Health Neurology CRO Services Introduction
11.9.4 Syneos Health Revenue in Neurology CRO Services Business (2020-2025)
11.9.5 Syneos Health Recent Development
11.10 Biotrial
11.10.1 Biotrial Company Details
11.10.2 Biotrial Business Overview
11.10.3 Biotrial Neurology CRO Services Introduction
11.10.4 Biotrial Revenue in Neurology CRO Services Business (2020-2025)
11.10.5 Biotrial Recent Development
11.11 Allucent
11.11.1 Allucent Company Details
11.11.2 Allucent Business Overview
11.11.3 Allucent Neurology CRO Services Introduction
11.11.4 Allucent Revenue in Neurology CRO Services Business (2020-2025)
11.11.5 Allucent Recent Development
11.12 Cromos Pharma
11.12.1 Cromos Pharma Company Details
11.12.2 Cromos Pharma Business Overview
11.12.3 Cromos Pharma Neurology CRO Services Introduction
11.12.4 Cromos Pharma Revenue in Neurology CRO Services Business (2020-2025)
11.12.5 Cromos Pharma Recent Development
11.13 Lindus Health
11.13.1 Lindus Health Company Details
11.13.2 Lindus Health Business Overview
11.13.3 Lindus Health Neurology CRO Services Introduction
11.13.4 Lindus Health Revenue in Neurology CRO Services Business (2020-2025)
11.13.5 Lindus Health Recent Development
11.14 TFS HealthScience
11.14.1 TFS HealthScience Company Details
11.14.2 TFS HealthScience Business Overview
11.14.3 TFS HealthScience Neurology CRO Services Introduction
11.14.4 TFS HealthScience Revenue in Neurology CRO Services Business (2020-2025)
11.14.5 TFS HealthScience Recent Development
11.15 Worldwide Clinical Trials
11.15.1 Worldwide Clinical Trials Company Details
11.15.2 Worldwide Clinical Trials Business Overview
11.15.3 Worldwide Clinical Trials Neurology CRO Services Introduction
11.15.4 Worldwide Clinical Trials Revenue in Neurology CRO Services Business (2020-2025)
11.15.5 Worldwide Clinical Trials Recent Development
11.16 Quotient Sciences
11.16.1 Quotient Sciences Company Details
11.16.2 Quotient Sciences Business Overview
11.16.3 Quotient Sciences Neurology CRO Services Introduction
11.16.4 Quotient Sciences Revenue in Neurology CRO Services Business (2020-2025)
11.16.5 Quotient Sciences Recent Development
11.17 PharPoint Research
11.17.1 PharPoint Research Company Details
11.17.2 PharPoint Research Business Overview
11.17.3 PharPoint Research Neurology CRO Services Introduction
11.17.4 PharPoint Research Revenue in Neurology CRO Services Business (2020-2025)
11.17.5 PharPoint Research Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1090 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 157
USD 4900.00
(Single User License)
The global Neurology CRO Services market was valued at US$ 763 million in 2025 and is anticipated to reach US$ 1090 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 127
USD 2900.00
(Single User License)
The global Neurology CRO Services market size was US$ 763 million in 2025 and is forecast to reach a readjusted size of US$ 1090 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 104
USD 4250.00
(Single User License)
The global market for Neurology CRO Services was estimated to be worth US$ 763 million in 2025 and is projected to reach US$ 1090 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 131
USD 3950.00
(Single User License)
The global market for Neurology CRO Services was estimated to be worth US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-05-08
Pages: 122
USD 3950.00
(Single User License)
The global Neurology CRO Services market size was US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-05-08
Pages: 106
USD 4250.00
(Single User License)
The global market for Neurology CRO Services was valued at US$ 724 million in the year 2024 and is projected to reach a revised size of US$ 1040 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published Date: 2025-05-08
Pages: 91
USD 2900.00
(Single User License)
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1090 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 157
The global Neurology CRO Services market was valued at US$ 763 million in 2025 and is anticipated to reach US$ 1090 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-11
Pages: 127
The global Neurology CRO Services market size was US$ 763 million in 2025 and is forecast to reach a readjusted size of US$ 1090 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 104
The global market for Neurology CRO Services was estimated to be worth US$ 763 million in 2025 and is projected to reach US$ 1090 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 131
The global market for Neurology CRO Services was estimated to be worth US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 122
The global Neurology CRO Services market size was US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 106
The global market for Neurology CRO Services was valued at US$ 724 million in the year 2024 and is projected to reach a revised size of US$ 1040 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published: 2025-05-08
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now